Clinical trials: Ovarian Stimulation
Fertility Preservation
FSH and LH Versus FSH Alone for Ovarian Stimulation in Non-hormone Sensitive Onco-fertility Patients
Fertility preservation has been performed before the initiation of cancer therapy as cancer therapy is known to be toxic for ovarian function.
- Trial name
- NCT06227949
- Testing
- Luveris
- Volunteers
- 140 people
- Sponsor
- Ellen Greenblatt
Infertility
Endometrial Scratching Prior to Controlled Ovarian Stimulation (COH) in Women Undergoing In-vitro Fertilization With Previous IVF Failure
Scratching the linning of the womb before IVF cycle could increase the chances of having a baby after an IVF cycle.
- Trial name
- ESICOHF (NCT01245309)
- Testing
- scratching
- Where
- Egypt
- Volunteers
- 500 people
- Sponsor
- Mansoura University
Infertility, Female, Ovarian Reserve
hCG Priming in Women With Diminished Ovarian Reserve
The aim of this randomized controlled trial is to further examine the possible effects of low dose human chorionic gonadotropin (hCG) priming for eight weeks in women with diminished ovarian reserve (DOR) undergoing in vitro…
- Conditions
- Infertility, Female, Ovarian Reserve, In Vitro Fertilization (IVF)
- Trial name
- NCT07108621
- Testing
- Choriongonadotropin alfa (hCG)
- Where
- Denmark
- Volunteers
- 80 people
- Sponsor
- Kristine Loessl
Controlled Ovarian Stimulation, Progesterone Variation on Trigger Day
Progesterone Variation on the Final Day of Oocyte Maturation.
The current study, aims through a robust design to provide a simple answer on whether progesterone levels of the same individual may significantly vary depending on the time of blood retrieval before the ovulation triggering, by…
- Conditions
- Controlled Ovarian Stimulation, Progesterone Variation on Trigger Day, Circadian Rhythm, Oocyte Donors
- Trial name
- NCT03366025
- Testing
- Serum progesterone measure
- Where
- Spain
- Volunteers
- 22 people, healthy volunteers welcome
- Sponsor
- Fundacion Dexeus
Hypogonadotropic Hypogonadism
Clinical Outcomes in WHO Type I Anovulatory Women Using r-hFSH+r-hLH in a 2:1 Ratio or hMG-HP
The aim of the study is to compare the efficacy and safety of r-hFSH+r-hLH in a 2:1 ratio with human Menopausal Gonadotropin Highly Purified (hMG-HP), in WHO type I anovulation, HH women.
- Trial name
- NCT01623570
- Testing
- Pergoveris: 150IU r-hFSH + 75IU r-hLH, Menopur: HMG-HP (150 IU)
- Where
- Italy
- Volunteers
- 40 people
- Sponsor
- Centro Riproduzione e Andrologia